TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmaust Limited ( (AU:NUZ) ) has shared an announcement.
Neurizon Therapeutics Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled for November 26, 2025, to be held as a hybrid meeting. This approach allows shareholders to attend either in person or virtually, reflecting recent legislative changes that offer more flexible communication options. The company has made its meeting materials, including the annual report, available online, encouraging shareholders to update their communication preferences to receive electronic documents. This move towards digital communication is expected to streamline operations and enhance shareholder engagement.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Neurizon Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of therapeutic solutions. The company is engaged in advancing medical treatments and is positioned in the market to offer innovative healthcare products.
Average Trading Volume: 728,742
Technical Sentiment Signal: Sell
Current Market Cap: A$72.17M
Learn more about NUZ stock on TipRanks’ Stock Analysis page.